Genexine Inc (095700) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genexine Inc (095700) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


  • Products Id :- GDPH137914D
  • |
  • Pages: 32
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Genexine Inc (Genexine), formerly Genexine Co Ltd is a clinical stage biotechnology company that develops and commercialize immunotherapeutics and next generation novel long-acting biologics. The company develops therapeutic vaccines for incurable diseases and next-generation antibody fusion protein drugs. Its pipeline products include GX-H9, GX-G8, GX-30, GX-188E, GX-17, GX-P2, GX-E2, GX-G3, and GX-G6. Genexine develops products for various therapeutic areas such as orphans, cancers and immune disorders. The company uses hybrid Fc technology platform for the discovery of a wide range of differentiated agonistic protein therapeutics. It partners with other pharmaceutical companies for its research and development activities. The company has operations in the US and South Korea. Genexine is headquartered in Seongnam, South Korea.

Genexine Inc (095700)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genexine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Genexine Inc, Medical Devices Deals, 2012 to YTD 2018 9

Genexine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Genexine Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Genexine Enters into Licensing Agreement with PharmaJet 11

NeoImmuneTech and Genexine Enter into Agreement with Roche 12

Genexine Enters into Clinical Research Agreement with Merck 13

Tasly Pharma to Form Joint Venture with CBC SPVII and Genexine 14

I-Bridge Capital, Shanghai Tasly Pharma and Genexine Form Joint Venture 15

Kalbe Farma and Genexine Form Joint Venture 16

Genexine and Ilko Ilac Form Joint Venture 17

Licensing Agreements 18

I-Mab Biopharma Enters into Licensing Agreement with Genexine 18

Shanghai ChemoWanbang Biopharma Enters into Licensing Agreement with Genexine 19

Tasly Pharma Enters into Licensing Agreement with Genexine 20

Equity Offering 21

Genexine Raises USD53 Million in Private Placement of Preferred Stock 21

Genexine to Raise USD17 Million in Private Placement of Shares 23

Debt Offering 24

Genexine Raises USD17.8 Million in Private Placement of Bonds 24

Genexine Inc-Key Competitors 25

Genexine Inc-Key Employees 26

Genexine Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Joint Venture 27

Recent Developments 28

Product News 28

07/18/2018: Hyleukin-7 selected as a Korea Drug Development Fund project for combination trial with Merck's KEYTRUDA 28

Clinical Trials 29

May 29, 2018: NeoImmuneTech Announces Initiation of HyLeukin-7 Clinical Development for Cancer Patients in the U.S. 29

Apr 03, 2017: Genexine Releases Positive Interim Phase 2 Clinical Data from PGHD Trial with long-acting growth hormone, GX-H9 at ENDO 2017 30

Jan 18, 2017: GX-G6 for Type 2 Diabetes, Receives Phase I IND Approval in Europe 31

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32

List of Figures

Genexine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genexine Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Genexine Inc, Medical Devices Deals, 2012 to YTD 2018 9

List of Tables

Genexine Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Genexine Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Genexine Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Genexine Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Genexine Inc, Medical Devices Deals, 2012 to YTD 2018 9

Genexine Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Genexine Enters into Licensing Agreement with PharmaJet 11

NeoImmuneTech and Genexine Enter into Agreement with Roche 12

Genexine Enters into Clinical Research Agreement with Merck 13

Tasly Pharma to Form Joint Venture with CBC SPVII and Genexine 14

I-Bridge Capital, Shanghai Tasly Pharma and Genexine Form Joint Venture 15

Kalbe Farma and Genexine Form Joint Venture 16

Genexine and Ilko Ilac Form Joint Venture 17

I-Mab Biopharma Enters into Licensing Agreement with Genexine 18

Shanghai ChemoWanbang Biopharma Enters into Licensing Agreement with Genexine 19

Tasly Pharma Enters into Licensing Agreement with Genexine 20

Genexine Raises USD53 Million in Private Placement of Preferred Stock 21

Genexine to Raise USD17 Million in Private Placement of Shares 23

Genexine Raises USD17.8 Million in Private Placement of Bonds 24

Genexine Inc, Key Competitors 25

Genexine Inc, Key Employees 26

Genexine Inc, Other Locations 27

Genexine Inc, Joint Venture 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Genexine Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 18225
Site License
USD 500 INR 36450
Corporate User License
USD 750 INR 54675

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com